clenbuterol has been researched along with cardiovascular agents in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banner, NR; Barton, PJ; Birks, EJ; Grindle, S; Hall, JL; Hardy, JP; Khaghani, A; Latif, N; Miller, LW; Rider, JE; Yacoub, MH | 1 |
Banner, NR; Birks, EJ; Bowles, CT; Burke, M; George, RS; Hardy, J; Khaghani, A; Tansley, PD; Yacoub, MH | 1 |
Amrani, M; Bahrami, T; Birks, EJ; Bougard, R; Bowles, CT; Dreyfus, G; George, RS; Hedger, M; Khaghani, A; Webb, C; Wilton, P; Yacoub, MH | 1 |
1 trial(s) available for clenbuterol and cardiovascular agents
Article | Year |
---|---|
Left ventricular assist device and drug therapy for the reversal of heart failure.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiovascular Agents; Clenbuterol; Combined Modality Therapy; Female; Heart Transplantation; Heart-Assist Devices; Humans; Male; Middle Aged; Oxygen; Prospective Studies; Prosthesis Failure; Survival Rate | 2006 |
2 other study(ies) available for clenbuterol and cardiovascular agents
Article | Year |
---|---|
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Cardiomyopathies; Cardiovascular Agents; Clenbuterol; Combined Modality Therapy; Convalescence; Cytoskeletal Proteins; Device Removal; Female; Gene Expression Profiling; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Integrins; Male; Middle Aged; Myocytes, Cardiac; Oligonucleotide Array Sequence Analysis; Postoperative Period; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome | 2005 |
Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study.
Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Clenbuterol; Female; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult | 2011 |